RPG Life Sciences share news and announcements
NSE: RPGLIFEBSE: 532983Pharmaceuticals & BiotechnologySmall Cap
Last close ₹2,619.60down ₹160.60 (5.78%)BSE ₹2,618.15
Share price at the NSE close on 23 Oct 2026. Previous close ₹2,780.20.
52-week range of traded prices to 23 Oct 2026
₹1,733.00Low, 23 Mar 2026₹3,127.80High, 25 Sep 2026
- Next results date: the board meets on 29 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,333 Cr923rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 36.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 7.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.92%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 21.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- 21.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.03
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,53144.4% delivered
RPG Life Sciences analyst meets
53 filed, newest first. Page 1 of 2.
Oct 2026
Sep 2026
17 Sep · Analysts
3 Sep · Analysts
2 Sep · Analysts
Aug 2026
25 Aug · Analysts
May 2026
22 May · Analysts
Apr 2026
23 Apr · Analysts
Oct 2025
14 Oct · Analysts
13 Oct · Analysts
Sep 2025
1 Sep · Analysts
Aug 2025
May 2025
Feb 2025
25 Feb · Analysts
Dec 2024
9 Dec · Analysts
Nov 2024
12 Nov · Analysts
Oct 2024
31 Oct · Analysts
Sep 2024
13 Sep · Analysts
Aug 2024
28 Aug · Analysts
8 Aug · Analysts
Jun 2024
11 Jun · Analysts
May 2024
30 May · Analysts
Apr 2024
26 Apr · Analysts
Feb 2024
21 Feb · Analysts
13 Feb · Analysts
Dec 2023
Oct 2023
13 Oct · Analysts
Jun 2023
Feb 2023
Dec 2022
Oct 2022
Sep 2022
Apr 2022
Feb 2022
9 Feb · Analysts
Oct 2021
20 Oct · Analysts
Aug 2021
Jun 2021
Jun 2019
Jun 2018
Nov 2017
Jun 2017
Nov 2016